Neurocrine Biosciences to Present at the Stifel 2025 Virtual CNS Forum
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at the Stifel 2025 Virtual CNS Forum at 1:30 p.m. Eastern Time on Tuesday, March 18, 2025. Chief Executive Officer Kyle Gano and Chief ...
Scotts Miracle-Gro rises on Stifel’s upgrade on valuation
Scotts Miracle-Gro (NYSE:SMG) on Tuesday rose as much as 5.8% after analysts at financial-services firm Stifel upgraded the ...
Oracle (NYSE:ORCL) Price Target Cut to $150.00 by Analysts at Stifel Nicolaus
Oracle (NYSE:ORCL – Free Report) had its price objective lowered by Stifel Nicolaus from $175.00 to $150.00 in a research note issued to investors on Tuesday morning,Benzinga reports. Stifel Nicolaus ...
Alnylam to Webcast Presentation at Stifel 2025 Virtual CNS Forum
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview at the Stifel 2025 Virtual CNS Forum on Tuesday, ...